市場調査レポート
商品コード
1601984

注射用ドラッグデリバリーの世界市場 2024年~2028年

Global Injectable Drug Delivery Devices Market 2024-2028


出版日
発行
TechNavio
ページ情報
英文 159 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
注射用ドラッグデリバリーの世界市場 2024年~2028年
出版日: 2024年11月09日
発行: TechNavio
ページ情報: 英文 159 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

注射用ドラッグデリバリー市場 2024年~2028年

注射用ドラッグデリバリー市場は2023年~2028年に295億6,290万米ドル、予測期間中のCAGRは10.8%で成長すると予測されます。当レポートでは、注射用ドラッグデリバリー市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。慢性疾患の増加、生物製剤産業の成長、ヘルスケアシステムのデジタル化などが市場を牽引しています。

市場範囲
基準年 2024年
終了年 2028年
予測期間 2024年~2028年
成長モメンタム 加速
前年比2024年 9.7%
CAGR 10.8%
増分額 295億6,290万米ドル

本調査では、今後数年間の注射用ドラッグデリバリー市場成長を牽引する主な要因の一つとして、新興国における高い成長可能性を挙げています。また、セルフ注射用ドラッグデリバリーの採用が拡大し、医薬品の研究開発への投資が増加することで、同市場には大きな需要が見込まれます。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio別分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023年
  • 市場の見通し 2023年~2028年

第5章 市場規模実績

  • 注射用ドラッグデリバリーの世界市場 2018年~2022年
  • 製品セグメント分析 2018年~2022年
  • 地域別セグメント分析 2018年~2022年
  • 国別セグメント分析 2018年~2022年

第6章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第7章 市場セグメンテーション:製品別

  • 市場セグメント
  • 比較:製品別
  • 高度な注射用ドラッグデリバリー:市場規模と予測 2023年~2028年
  • 従来の注射用ドラッグデリバリー:市場規模と予測 2023年~2028年
  • 市場機会:製品別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023年~2028年
  • 欧州:市場規模と予測 2023年~2028年
  • アジア:市場規模と予測 2023年~2028年
  • 世界のその他の地域:市場規模と予測 2023年~2028年
  • 米国:市場規模と予測 2023年~2028年
  • 中国:市場規模と予測 2023年~2028年
  • 英国:市場規模と予測 2023年~2028年
  • カナダ:市場規模と予測 2023年~2028年
  • 日本:市場規模と予測 2023年~2028年
  • インド:市場規模と予測 2023年~2028年
  • ドイツ:市場規模と予測 2023年~2028年
  • 韓国:市場規模と予測 2023年~2028年
  • フランス:市場規模と予測 2023年~2028年
  • オランダ:市場規模と予測 2023年~2028年
  • 市場機会:地域情勢別

第10章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第11章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第12章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • AstraZeneca Plc
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • Eli Lilly and Co.
  • Gerresheimer AG
  • Owen Mumford Ltd.
  • Sanofi SA
  • SCHOTT AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Company Market Positioning
  • Exhibits9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits10: Overview on criticality of inputs and factors of differentiation
  • Exhibits11: Overview on factors of disruption
  • Exhibits12: Impact of drivers and challenges in 2023 and 2028
  • Exhibits13: Parent Market
  • Exhibits14: Data Table on - Parent Market
  • Exhibits15: Market characteristics analysis
  • Exhibits16: Value Chain Analysis
  • Exhibits17: Offerings of companies included in the market definition
  • Exhibits18: Market segments
  • Exhibits19: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits20: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits21: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits22: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits23: Historic Market Size - Data Table on Global Injectable Drug Delivery Devices Market 2018 - 2022 ($ million)
  • Exhibits24: Historic Market Size - Product Segment 2018 - 2022 ($ million)
  • Exhibits25: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits26: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits27: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits28: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits29: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits31: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits32: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits33: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits34: Chart on Product - Market share 2023-2028 (%)
  • Exhibits35: Data Table on Product - Market share 2023-2028 (%)
  • Exhibits36: Chart on Comparison by Product
  • Exhibits37: Data Table on Comparison by Product
  • Exhibits38: Chart on Advanced injectable drug delivery devices - Market size and forecast 2023-2028 ($ million)
  • Exhibits39: Data Table on Advanced injectable drug delivery devices - Market size and forecast 2023-2028 ($ million)
  • Exhibits40: Chart on Advanced injectable drug delivery devices - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Advanced injectable drug delivery devices - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Conventional injectable drug delivery devices - Market size and forecast 2023-2028 ($ million)
  • Exhibits43: Data Table on Conventional injectable drug delivery devices - Market size and forecast 2023-2028 ($ million)
  • Exhibits44: Chart on Conventional injectable drug delivery devices - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Conventional injectable drug delivery devices - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Market opportunity by Product ($ million)
  • Exhibits47: Data Table on Market opportunity by Product ($ million)
  • Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits49: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits51: Chart on Geographic comparison
  • Exhibits52: Data Table on Geographic comparison
  • Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits74: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits76: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits79: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on India - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on India - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on The Netherlands - Market size and forecast 2023-2028 ($ million)
  • Exhibits106: Data Table on The Netherlands - Market size and forecast 2023-2028 ($ million)
  • Exhibits107: Chart on The Netherlands - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on The Netherlands - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Market opportunity By Geographical Landscape ($ million)
  • Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits111: Impact of drivers and challenges in 2023 and 2028
  • Exhibits112: Overview on criticality of inputs and factors of differentiation
  • Exhibits113: Overview on factors of disruption
  • Exhibits114: Impact of key risks on business
  • Exhibits115: Companies covered
  • Exhibits116: Company ranking index
  • Exhibits117: Matrix on companies position and classification
  • Exhibits118: AstraZeneca Plc - Overview
  • Exhibits119: AstraZeneca Plc - Product / Service
  • Exhibits120: AstraZeneca Plc - Key news
  • Exhibits121: AstraZeneca Plc - Key offerings
  • Exhibits122: SWOT
  • Exhibits123: Baxter International Inc. - Overview
  • Exhibits124: Baxter International Inc. - Business segments
  • Exhibits125: Baxter International Inc. - Key news
  • Exhibits126: Baxter International Inc. - Key offerings
  • Exhibits127: Baxter International Inc. - Segment focus
  • Exhibits128: SWOT
  • Exhibits129: Becton Dickinson and Co. - Overview
  • Exhibits130: Becton Dickinson and Co. - Business segments
  • Exhibits131: Becton Dickinson and Co. - Key news
  • Exhibits132: Becton Dickinson and Co. - Key offerings
  • Exhibits133: Becton Dickinson and Co. - Segment focus
  • Exhibits134: SWOT
  • Exhibits135: Eli Lilly and Co. - Overview
  • Exhibits136: Eli Lilly and Co. - Product / Service
  • Exhibits137: Eli Lilly and Co. - Key offerings
  • Exhibits138: SWOT
  • Exhibits139: Gerresheimer AG - Overview
  • Exhibits140: Gerresheimer AG - Business segments
  • Exhibits141: Gerresheimer AG - Key news
  • Exhibits142: Gerresheimer AG - Key offerings
  • Exhibits143: Gerresheimer AG - Segment focus
  • Exhibits144: SWOT
  • Exhibits145: Owen Mumford Ltd. - Overview
  • Exhibits146: Owen Mumford Ltd. - Product / Service
  • Exhibits147: Owen Mumford Ltd. - Key offerings
  • Exhibits148: SWOT
  • Exhibits149: Sanofi SA - Overview
  • Exhibits150: Sanofi SA - Business segments
  • Exhibits151: Sanofi SA - Key news
  • Exhibits152: Sanofi SA - Key offerings
  • Exhibits153: Sanofi SA - Segment focus
  • Exhibits154: SWOT
  • Exhibits155: SCHOTT AG - Overview
  • Exhibits156: SCHOTT AG - Product / Service
  • Exhibits157: SCHOTT AG - Key offerings
  • Exhibits158: SWOT
  • Exhibits159: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits160: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits161: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits162: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits163: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits164: SWOT
  • Exhibits165: Viatris Inc. - Overview
  • Exhibits166: Viatris Inc. - Business segments
  • Exhibits167: Viatris Inc. - Key news
  • Exhibits168: Viatris Inc. - Key offerings
  • Exhibits169: Viatris Inc. - Segment focus
  • Exhibits170: SWOT
  • Exhibits171: Inclusions checklist
  • Exhibits172: Exclusions checklist
  • Exhibits173: Currency conversion rates for US$
  • Exhibits174: Research methodology
  • Exhibits175: Information sources
  • Exhibits176: Data validation
  • Exhibits177: Validation techniques employed for market sizing
  • Exhibits178: Data synthesis
  • Exhibits179: 360 degree market analysis
  • Exhibits180: List of abbreviations
目次
Product Code: IRTNTR72265

Injectable Drug Delivery Devices Market 2024-2028

The injectable drug delivery devices market is forecasted to grow by USD 29562.9 mn during 2023-2028, accelerating at a CAGR of 10.8% during the forecast period. The report on the injectable drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases, growing biologics industry, and digitalization in healthcare system.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20249.7%
CAGR10.8%
Incremental Value$29562.9 mn

Technavio's injectable drug delivery devices market is segmented as below:

By Product

    • Advanced injectable drug delivery devices
    • Conventional injectable drug delivery devices

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the high growth potential in emerging countries as one of the prime reasons driving the injectable drug delivery devices market growth during the next few years. Also, growing adoption of self-injectable drug delivery devices and increasing investments in pharmaceutical research and development will lead to sizable demand in the market.

The report on the injectable drug delivery devices market covers the following areas:

    • Injectable Drug Delivery Devices Market sizing
    • Injectable Drug Delivery Devices Market forecast
    • Injectable Drug Delivery Devices Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading injectable drug delivery devices market vendors that include Antares Pharma Inc., AstraZeneca Plc, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Bespak Europe Ltd., Credence MedSystems Inc., E3D Elcam Drug Delivery Devices, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gerresheimer AG, Insulet Corp., Owen Mumford Ltd., Sanofi SA, SCHOTT AG, SHL Medical AG, Terumo Corp., Teva Pharmaceutical Industries Ltd., Viatris Inc., and West Pharmaceutical Services Inc.. Also, the injectable drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value Chain Analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2023
  • 4.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

  • 5.1 Global Injectable Drug Delivery Devices Market 2018 - 2022
    • Historic Market Size - Data Table on Global Injectable Drug Delivery Devices Market 2018 - 2022 ($ million)
  • 5.2 Product segment analysis 2018 - 2022
    • Historic Market Size - Product Segment 2018 - 2022 ($ million)
  • 5.3 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 5.4 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Five Forces Analysis

  • 6.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 6.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 6.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 6.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 6.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 6.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 6.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

7 Market Segmentation by Product

  • 7.1 Market segments
    • Chart on Product - Market share 2023-2028 (%)
    • Data Table on Product - Market share 2023-2028 (%)
  • 7.2 Comparison by Product
    • Chart on Comparison by Product
    • Data Table on Comparison by Product
  • 7.3 Advanced injectable drug delivery devices - Market size and forecast 2023-2028
    • Chart on Advanced injectable drug delivery devices - Market size and forecast 2023-2028 ($ million)
    • Data Table on Advanced injectable drug delivery devices - Market size and forecast 2023-2028 ($ million)
    • Chart on Advanced injectable drug delivery devices - Year-over-year growth 2023-2028 (%)
    • Data Table on Advanced injectable drug delivery devices - Year-over-year growth 2023-2028 (%)
  • 7.4 Conventional injectable drug delivery devices - Market size and forecast 2023-2028
    • Chart on Conventional injectable drug delivery devices - Market size and forecast 2023-2028 ($ million)
    • Data Table on Conventional injectable drug delivery devices - Market size and forecast 2023-2028 ($ million)
    • Chart on Conventional injectable drug delivery devices - Year-over-year growth 2023-2028 (%)
    • Data Table on Conventional injectable drug delivery devices - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Product
    • Market opportunity by Product ($ million)
    • Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.9 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.10 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.11 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ million)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.12 India - Market size and forecast 2023-2028
    • Chart on India - Market size and forecast 2023-2028 ($ million)
    • Data Table on India - Market size and forecast 2023-2028 ($ million)
    • Chart on India - Year-over-year growth 2023-2028 (%)
    • Data Table on India - Year-over-year growth 2023-2028 (%)
  • 9.13 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.14 South Korea - Market size and forecast 2023-2028
    • Chart on South Korea - Market size and forecast 2023-2028 ($ million)
    • Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
    • Chart on South Korea - Year-over-year growth 2023-2028 (%)
    • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • 9.15 France - Market size and forecast 2023-2028
    • Chart on France - Market size and forecast 2023-2028 ($ million)
    • Data Table on France - Market size and forecast 2023-2028 ($ million)
    • Chart on France - Year-over-year growth 2023-2028 (%)
    • Data Table on France - Year-over-year growth 2023-2028 (%)
  • 9.16 The Netherlands - Market size and forecast 2023-2028
    • Chart on The Netherlands - Market size and forecast 2023-2028 ($ million)
    • Data Table on The Netherlands - Market size and forecast 2023-2028 ($ million)
    • Chart on The Netherlands - Year-over-year growth 2023-2028 (%)
    • Data Table on The Netherlands - Year-over-year growth 2023-2028 (%)
  • 9.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Company ranking index
    • Company ranking index
  • 12.3 Market positioning of companies
    • Matrix on companies position and classification
  • 12.4 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
    • SWOT
  • 12.5 Baxter International Inc.
    • Baxter International Inc. - Overview
    • Baxter International Inc. - Business segments
    • Baxter International Inc. - Key news
    • Baxter International Inc. - Key offerings
    • Baxter International Inc. - Segment focus
    • SWOT
  • 12.6 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
    • SWOT
  • 12.7 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key offerings
    • SWOT
  • 12.8 Gerresheimer AG
    • Gerresheimer AG - Overview
    • Gerresheimer AG - Business segments
    • Gerresheimer AG - Key news
    • Gerresheimer AG - Key offerings
    • Gerresheimer AG - Segment focus
    • SWOT
  • 12.9 Owen Mumford Ltd.
    • Owen Mumford Ltd. - Overview
    • Owen Mumford Ltd. - Product / Service
    • Owen Mumford Ltd. - Key offerings
    • SWOT
  • 12.10 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 12.11 SCHOTT AG
    • SCHOTT AG - Overview
    • SCHOTT AG - Product / Service
    • SCHOTT AG - Key offerings
    • SWOT
  • 12.12 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus
    • SWOT
  • 12.13 Viatris Inc.
    • Viatris Inc. - Overview
    • Viatris Inc. - Business segments
    • Viatris Inc. - Key news
    • Viatris Inc. - Key offerings
    • Viatris Inc. - Segment focus
    • SWOT

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations